Haemonetics
HAE
120.16
-0.21
-0.17%
Haemonetics
US · HAE
#2165 by market cap
Listed 1970
120.16
-0.21
-0.17%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
2 2
■ Upgrades■ Downgrades
- 2 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: Citi moved from Hold to Buy on 2026-09-17.
Analyst consensus 10 analysts
Buy
Avg price target 145.75 +21.3%
Price target rangecurrent 120.16
Low125.00
Avg145.75
High165.00
Buy 80%
Hold 20%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-13 | Jefferies | -- | Buy | 150.00 |
| 2026-11-09 | J.P. Morgan | -- | Hold | 125.00 |
| 2026-11-06 | Barrington | -- | Buy | 145.00 |
| 2026-11-06 | Mizuho Securities | -- | Buy | 165.00 |
| 2026-11-06 | BofA Securities | -- | Buy | -- |
| 2026-11-06 | Baird | -- | Buy | 165.00 |
| 2026-11-06 | Citi | -- | Buy | 149.00 |
| 2026-11-05 | BTIG | -- | Buy | 142.00 |
| 2026-10-26 | Barrington | -- | Buy | 140.00 |
| 2026-10-21 | Needham | -- | Hold | -- |
| 2026-10-19 | BTIG | -- | Buy | 130.00 |
| 2026-10-09 | Barrington | -- | Buy | 140.00 |
| 2026-10-09 | Mizuho Securities | -- | Buy | 140.00 |
| 2026-10-08 | BTIG | -- | Buy | 130.00 |
| 2026-10-08 | BofA Securities | -- | Buy | 140.00 |
| 2026-10-01 | Barrington | -- | Buy | 118.00 |
| 2026-09-18 | Citi | -- | Buy | 123.00 |
| 2026-09-17 | Citi | -- | Buy | 123.00 |
| 2026-09-03 | Raymond James | -- | Buy | 125.00 |
| 2026-08-21 | Baird | -- | Buy | 119.00 |
| 2026-08-19 | Barrington | -- | Buy | 118.00 |
| 2026-08-18 | BofA Securities | -- | Buy | 120.00 |
| 2026-08-18 | Needham | -- | Hold | -- |
| 2026-08-17 | BofA Securities | -- | Buy | 120.00 |
| 2026-08-13 | Citi | -- | Hold | 92.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-17 | Citi | Hold → Buy | 123.00 |
| 2026-05-22 | BofA Securities | Hold → Buy | 80.00 |
| 2025-12-15 | Needham | Buy → Hold | -- |
| 2025-12-11 | Citi | Buy → Hold | 88.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2027/Q2 | 2026-11-05 | -- | ±9.96% | -2.60% (in line) |
| 2027/Q1 | 2026-08-06 | -- | ±10.14% | +1.70% (in line) |
| 2026/Q4 | 2026-05-07 | -- | ±10.65% | +3.23% (in line) |
| 2026/Q3 | 2026-02-05 | -- | ±11.31% | -1.41% (in line) |
| 2026/Q2 | 2025-11-06 | -- | ±12.33% | +32.31% (beat) |
| 2026/Q1 | 2025-08-07 | -- | ±9.46% | -26.58% (beat) |
| 2025/Q4 | 2025-05-08 | -- | ±10.84% | +5.85% (in line) |
| 2025/Q3 | 2025-02-06 | -- | ±11.44% | -11.58% (beat) |
| 2025/Q2 | 2024-11-07 | -- | ±11.30% | +10.71% (in line) |
| 2025/Q1 | 2024-08-08 | -- | ±6.42% | -10.84% (beat) |
| 2024/Q4 | 2024-05-09 | -- | ±8.34% | -0.70% (in line) |
| 2024/Q3 | 2024-02-08 | -- | ±9.07% | +1.30% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Haemonetics discussion 0 comments